ARCHIVES

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

This article is from The Cancer Letter archive.

Vol. 33 No. 13 | April 6, 2007

Download PDF Visit The Full Archive

Related Articles

Klausner Unveils New NCI Structure, Aims To Change Institute’s “Ethos”

August 11, 1995

NCI Recruiting Senior Scientist To Lead AIDS research

May 17, 1996

Acting Commissioner Tells Grassley He Supports “Academic Freedom” at The Agency, but “At A Proper Time.”

December 1, 2006

Georgetown Sponsors Oncology Agent Development Meeting

March 21, 2003

In Brief: Broder Invokes Cancer Act Provision To Inform Hammer, Bush Of Potential Damage Of 32% Cut

September 7, 1990

Clinical Trials Approved By NCI CTEP Last Month

May 27, 2011